Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2011-03-01
2011-03-01
Parkin, Jeffrey S. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S007100, C424S148100, C424S160100
Reexamination Certificate
active
07897332
ABSTRACT:
The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.
REFERENCES:
patent: 4886742 (1989-12-01), Kortright et al.
patent: 4888290 (1989-12-01), Kortright et al.
patent: 4945042 (1990-07-01), Geiger et al.
patent: 5055391 (1991-10-01), Montagnier et al.
patent: 5156949 (1992-10-01), Luciw et al.
patent: 5173399 (1992-12-01), Mehta et al.
patent: 5210181 (1993-05-01), Butman et al.
patent: 5514541 (1996-05-01), Butman et al.
patent: 5612453 (1997-03-01), Wolf et al.
patent: 5627026 (1997-05-01), O'Connor et al.
patent: 5731189 (1998-03-01), Zolla-Pazner et al.
patent: 6593079 (2003-07-01), Donie et al.
patent: 6818392 (2004-11-01), Lou et al.
patent: 2003/0049604 (2003-03-01), Charneau et al.
patent: 4236189 (1994-04-01), None
patent: 19727943 (1998-09-01), None
patent: 19727943 (1998-09-01), None
patent: 186799 (1986-07-01), None
patent: 186799 (1986-07-01), None
patent: 246829 (1987-11-01), None
patent: 265851 (1988-05-01), None
patent: 280211 (1988-08-01), None
patent: 034561 (1989-12-01), None
patent: 345375 (1989-12-01), None
patent: 351248 (1990-01-01), None
patent: 386713 (1990-09-01), None
patent: 0519866 (1992-12-01), None
patent: 595211 (1994-05-01), None
patent: 345461 (1994-09-01), None
patent: 9014358 (1990-11-01), None
patent: WO 93/21346 (1993-10-01), None
patent: WO9429725 (1994-12-01), None
patent: WO9523973 (1995-09-01), None
patent: WO9603423 (1996-02-01), None
patent: WO9603651 (1996-02-01), None
patent: WO9603652 (1996-02-01), None
patent: WO9612809 (1996-05-01), None
patent: 9840744 (1998-09-01), None
Max, E. E., “Immunoglobulins: Molecular Genetics”, in Fundamental Immunology, Fourth Edition, Paul, W. E., ed., Lippincott-Raven Publishers, Philadelphia, 1999, pp. 142-143.
Weber, B., et al., 2002, Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, Vidas HIV Duo Ultra, J. Clin. Microbiol. 40(4):1420-1426.
Sickinger, E., et al., 2004, Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen, J. Clin. Microbiol. 42(1):21-29.
Niedrig, M. et al., “Characterization of Murine Monoclonal Antibodies Directed Against the core Proteins of Human Immunodeficiency Virus Types 1 and 2,” Journal of Virology, 65/8:4529-4533 (1991).
Minassian, A.A, et al., “Monoclonal Antibodies Against Human Immunodeficiency Virus HIV Type 2 Core Proteins Cross-Reactivity With HIV Type 1 and Simian Immunodeficiency Virus,” Proceedings of the national Academy of Sciences of the United States, 6/18:6939-6943 (1988).
Zolla-Pazner, Susan, et al., “The Implication of Antigenic Diversity for Vaccine Development,” Immunology Letters, 66/1-3: 159-164 (Mar. 1999).
Allain, et al.,The Lancet, Serological Markers in Early Stages of Human Immunodeficiency Virus Infection in Haemophiliacs, ii:1233-1236 (1986).
Barin, et al.,Science, Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS Patients, 228:1094-1096 (1985).
Barin, et al.,The Lancet, Serological Evidence for Virus Related to Simian T-Lymphotropic Retrovirus III in Residents of West Africa, 2:1387-1389 (1985).
Bowen, et al.,Annals of Internal Medicine, Transmission of Human Immunodeficiency Virus (HIV) by Transplantation: Clinical Aspects and Time Course Analysis of Viral Antigenemia and Antibody Production, Ann. Of Int. Med. 108:46-48 (1988).
Chameau, et al.,Virology, Isolation and Envelope Sequence of a Highly Divergent HIV-1 Isolate: Definition of a New HIV-1 Group, 205:247-253 (1994).
Clavel, et al.,Science, Isolation of a New Human Retrovirus from West Africa Patients with AIDS, 233:343-346 (1986).
Clavel, et al.,Nature, Molecular Cloning and Polymorphism of the Human Immune Deficiency Virus Type 2, 324:691-695 (1986).
Coffin,Science, HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis and Therapy, 267:483-489 (1995).
Courouce, et al., La Gazette de la Transfusion N°155-Mars-Avril (1999).
Dawson, et al.,The Journal of Infectious Diseases, Reliable Detection of Individuals Seropositive for the Human Immunodeficiency Virus (HIV) by Competitive Immunoassays UsingEscherichia coli-Expressed HIV Structural Proteins, 157:149-155 (1988).
Devare, et al.,Human Immunodeficiency Virus: Innovative Techniques, Monograph in Virology, Diagnosis and Monitoring of HIV-1 and HIV-2 Infection, J.L. Melnick (ed.) Basel, Karger, vol. 18: 105-121 (1990).
Euler, et al.,Clinical and Experimental Immunology, Precipitable Immune Complexes in Healthy Homosexual Men, Acquired Immune Deficiency Syndrome and the Related Lymphadenopathy Syndrome, 59:267-275 (1985).
Gao, F., et al.,Nature, Origin of HIV-1 in the Chimpanzee Pan Troglodytes Troglodytes, 397:436-441 (1999).
Gonda, et al.,Science, Sequence Homology and Morphologic Similarity of HTLV-III and Visna Virus, a Pathogenic Lentivirus, 277:177-179 (1985).
Goudsmit, et al.,The Lancet, Expression of Human Immunodeficiency Virus Antigen (HIV-Ag) in Serum and Cerebrospinal Fluid During Acute and Chronic Infection, ii:177-180 (1986).
Griffith, et al.,Journal of Clinical Microbiology, Stability of Free and Complexed Human Immunodeficiency Virus Type 1 and Antigen at 4° C. and at Room Temperature, 33:1348-1350 (1995).
Gupta, et al.,New England Journal of Medicine, Correspondence: Circulating Immune Complexes in AIDS, 310:1530-1531 (1984).
Gurtler, et al.,Journal of Virological Methods, Reactivity of Five Anti-HIV-1 Subtype O Specimens with Six Different Anti-HIV Screening ELISAs and Three Immunoblots, 51:177-184 (1995).
Gurtler, et al.,Journal of Virological Methods, Reduction of the Diagnostic Window with a New Combined p24 Antigen and Human Immunodeficiency Virus Antibody Screening Assay, 75:27-38 (1998).
Gurtler, et al.,Journal of Virological Methods, A New Subtype of Human Immunodeficiency Virus Type 1 (MVP-5180) From Cameroon, 68:1581-1585 (1994).
Guyader, et al.,Nature, Genome Organization and Transactivation of the Human Immunodeficiency Virus Type 2, 326:662-669 (1987).
Haesevelde, et al.,Journal of Virology, Genomic Cloning and Complete Sequence Analysis of a Highly Divergent African Human Immunodeficiency Virus Isolate, 68:1586-1596 (1994).
Hunt, et al.,AIDS Research and Human Retroviruses, Envelope Sequence Variability and Serologic Characterization of HIV Type 1 Group O Isolates from Equatorial Guinea, 13:995-1005 (1997).
Kageyama, et al.,Journal of Virological Methods, An Improved Method for the Detection of HIV Antigen in the Blood of Carriers, 22:125-131 (1988).
Kanki, et al.,Science, New Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-IIIAGM), 232:238-243 (1986).
Kanki, et al.,Science, Human T-Lymphotropic Virus Type 4 and the Human Immunodeficiency Virus in West Africa, 236:827-831 (1987).
Karush,F. In Comprehensive Immunology, ed. R.A. Good, S.B. Day, The Affinity of Antibody: Range, Variability and the Role of Multivalence, 5:85-116 (1978).
Kenny, et al.,The Lancet, HIV Antigen Testing, 1(8532):565-566 (1987).
Kessler, et al.,JAMA, Diagnosis of Human Immunodeficiency Virus Infection in Seronegative Homosexuals Presenting with an Acute Viral Syndrome, 258:1196-1199 (1987).
Ly, et al.,Journal of Clinical Microbiology, Contribution of Combined Detection Assays of P-24 Antigen and Anti-Human Immunodeficiency Virus (HIV) Antibodies in Diagnosis of Primary HIV Infection by Routine Testing, 38(6): 2459-2461 (2000).
Mariuzza, et al.,Rev. Biophys. Chem., The Structural Basis of Antigen-Antibody Recognition, 16:139-159 (1987).
Mathiesen, et al.,Journal of Virological Methods, Acid Hydroloysis of Serum Samples to Increase Detection of
Hunt Jeffrey C.
Konrath John G.
Lou Sheng C.
Qiu Xiaoxing
Scheffel James W.
Abbott Laboratories
Bartnicki Audrey L.
Larcher Carol
Larcher & Chao Law Group
Parkin Jeffrey S.
LandOfFree
Methods for the detection of HIV-1 or -2 antigens employing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the detection of HIV-1 or -2 antigens employing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the detection of HIV-1 or -2 antigens employing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2673238